Kijimea Irritable Bowel Syndrome is a Class IIb approved medical device for the treatment of irritable bowel syndrome (IBS) and its typical symptoms: constipation, diarrhea, abdominal pain, flatulence, and bloating. No adverse effects or interactions have been reported. The active ingredient in Kijimea Irritable Bowel Syndrome is the exclusive bifidobacteria strain B. bifidum MIMBb75. A study conducted exclusively for Kijimea Irritable Bowel Syndrome (IBS) demonstrated significant relief from irritable bowel syndrome and an improved quality of life for those affected. It contains no preservatives, sweeteners, artificial flavors, lactose, or gluten, and is the ideal solution for patients with diabetes. Kijimea Irritable Bowel Syndrome (IBS) also does not contain gelatin.
